spectracef 200 mg 500 comprimits coberta pelic
meiact 200 mg 500 comprimits recoberts pel·lícula
spectracef 400 mg 500 comprimits coberta pelic
meiact 400 mg 500 comprimits recoberts pel·lícula
spectracef 200 mg 20 comprimits coberta pelic
meiact 200 mg 20 comprimits recubietos pel·lícula
spectracef 400 mg 10 comprimits coberta pelic
meiact 400 mg 10 comprimits recoberts pel·lícula
cefditoren pivoxil tablet, film coated
pharma romlev inc. - cefditoren pivoxil (unii: 78tha212dh) (cefditoren - unii:81qs09v3yw) - cefditoren 200 mg - cefditoren pivoxil is indicated for the treatment of mild to moderate infections in adults and adolescents (12 years of age or older) which are caused by susceptible strains of the designated microorganisms in the conditions listed below. acute bacterial exacerbation of chronic bronchitis caused by haemophilus influenzae (including ß-lactamase-producing strains), haemophilus parainfluenzae (including ß-lactamase producing strains), streptococcus pneumoniae (penicillin susceptible strains only), or moraxella catarrhalis (including ß-lactamase-producing strains). community-acquired pneumonia caused by haemophilus influenzae (including ß-lactamase-producing strains), haemophilus parainfluenzae (including ß-lactamase-producing strains), streptococcus pneumoniae (penicillin-susceptible strains only), or moraxella catarrhalis (including ß-lactamase producing strains). pharyngitis/tonsillitis caused by streptococcus pyogenes . note: cefditoren pivoxil is effective in the eradication of streptococcus pyoge
spectracef- cefditoren pivoxil tablet, film coated spectracef- cefditoren pivoxil tablet, film coated
vansen pharma inc. - cefditoren pivoxil (unii: 78tha212dh) (cefditoren - unii:81qs09v3yw) - cefditoren 200 mg - spectracef® (cefditoren pivoxil) is indicated for the treatment of mild to moderate infections in adults and adolescents (12 years of age or older) which are caused by susceptible strains of the designated microorganisms in the conditions listed below. acute bacterial exacerbation of chronic bronchitis caused by haemophilus influenzae (including ß-lactamase-producing strains), haemophilus parainfluenzae (including ß-lactamase producing strains), streptococcus pneumoniae (penicillin susceptible strains only), or moraxella catarrhalis (including ß-lactamase-producing strains). community-acquired pneumonia caused by haemophilus influenzae (including ß-lactamase-producing strains), haemophilus parainfluenzae (including ß-lactamase-producing strains), streptococcus pneumoniae (penicillin-susceptible strains only), or moraxella catarrhalis (including ß-lactamase producing strains). pharyngitis/tonsillitis caused by streptococcus pyogenes . note: spectracef® is effective in the eradication of streptococcu